Improving cognitive control in Parkinson's patients using electrical stimulation
Official title: Modulation of Cognitive Control Via Transcranial Continuous Electrical Stimulation of Additional Motor Areas in Parkinson's Patients
Run by Assistance Publique Hopitaux De Marseille · NCT04897633 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing if a special type of brain stimulation can help people with Parkinson's disease improve their ability to control impulsive actions while they are on their medication.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 72 (estimated) |
| Sponsor | Assistance Publique Hopitaux De Marseille Academic / other |
| Locations | 1 site (Marseille) |
| Trial ID | NCT04897633 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults over 18 with idiopathic Parkinson's disease who are on dopaminergic treatment and have no significant cognitive deterioration.
✕Probably not a fit
Patients with uncorrected visual acuity issues, recent changes in psychotropic treatment, or those with certain medical devices like pacemakers may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effects of transcranial direct current stimulation (tDCS) on cognitive control in patients with Parkinson's disease who are undergoing dopaminergic treatment. The research aims to determine if cathodal stimulation of the Supplementary Motor Areas can enhance the ability to correct impulsive responses, which are often impaired in these patients. Participants will engage in a reaction time task, known as Simon's task, both with and without the stimulation to assess its impact on error correction. The study is designed as a single-center, single-blind, randomized trial.
Why it matters
Potential benefit: If successful, this approach could significantly improve cognitive control and reduce impulsivity in Parkinson's patients, enhancing their overall quality of life.
How similar studies have gone: Previous studies have shown promising results with tDCS in improving cognitive functions, suggesting potential success for this approach in Parkinson's disease.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria for Parkinsonien patients: * Age\> 18 years old * Idiopathic Parkinson's disease meeting the diagnostic criteria as defined by Ward and Gibb (1990) * Patients usually taking dopaminergic treatment. * No cognitive deterioration with: a Montreal Cognitive Assessment (MoCA) score ≥ 26 * Patient with Parkinson's disease in the advanced motor complications stage for which surgical treatment is being considered Inclusion Criteria for healthy subjects * Age\> = 18 years old * Patient free from Idiopathic Parkinson's Disease * No cognitive deterioration: MMSE (MiniMentalSate Evaluation)\> 26 Exclusion Criteria for both parkinsonien patients an healthy volunteers: * Uncorrected altered visual acuity * Dyschromatopsia (especially color blindness) * Psychotropic treatment introduced or modified recently (\<1 month) * Wearing a pacemaker (Pace Maker or Implantable Defibrillator) * Pregnancy (verified by a urine pregnancy test for women of childbearing age) * Other central nervous system disease (other parkinsonian syndrome, epilesia, stroke, etc.) or peripheral * Intracranial metal implants on the cephalic stage and cochlear implant * Untreated progressive mood or psycho-behavioral disorder * Severe and poorly controlled eczema Exclusion criteria for Parkinson's patients only: * Significant and disabling abnormal movement, not allowing good acquisition of the EMG signal (tremors or dyskinesias) * Wearer of a Deep Brain Stimulation device (CI at tDCS).
Where it's running
-
Service Neurologie et pathologies du mouvement
Marseille, France Recruiting
Study contacts
- Study coordinator: Frederique Fluchere, MD
- Email: frederique.fluchere@ap-hm.fr
- Phone: 0491389368
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Tributyrin for PSP: a virtual, early-phase study
This study tests whether tributyrin is safe and tolerable in people with Progressive Supranuclear Palsy who are 45 or older, using virtual visits.
-
A look at why Lewy body conditions cause visual hallucinations
This study tests brain‑imaging in people with Lewy body diseases who do or don’t experience visual hallucinations, and in healthy volunteers, to see how brain networks might create these images.
-
How physical activity might help people with Parkinson’s disease who have DBS-STN implants
This study tests whether adding regular physical activity can help people with Parkinson’s who have DBS-STN stimulation by trying a structured physiotherapy approach alongside standard care.
-
Can hippotherapy improve mobility, gait, balance, and quality of life in people with Parkinson's disease?
This pilot trial tests whether adding horse-assisted therapy to standard rehab helps mobility, gait, balance, and perceived health in adults with Parkinson's disease.
-
Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns
This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.